These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 15306636)
1. Effects of rapamycin on cardiac and skeletal muscle contraction and crossbridge cycling. Schoffstall B; Kataoka A; Clark A; Chase PB J Pharmacol Exp Ther; 2005 Jan; 312(1):12-8. PubMed ID: 15306636 [TBL] [Abstract][Full Text] [Related]
2. Secophalloidin and phalloidin-(S)-sulfoxide as contraction modifiers for comparative study of skeletal and cardiac muscles. Bukatina AE; Kirkpatrick RD; Campbell KB Tsitologiia; 2000; 42(1):37-41. PubMed ID: 10709250 [TBL] [Abstract][Full Text] [Related]
3. Computational simulation of hypertrophic cardiomyopathy mutations in troponin I: influence of increased myofilament calcium sensitivity on isometric force, ATPase and [Ca2+]i. Kataoka A; Hemmer C; Chase PB J Biomech; 2007; 40(9):2044-52. PubMed ID: 17140583 [TBL] [Abstract][Full Text] [Related]
4. Regulation of contraction kinetics in skinned skeletal muscle fibers by calcium and troponin C. Luo Y; Rall JA Arch Biochem Biophys; 2006 Dec; 456(2):119-26. PubMed ID: 16764818 [TBL] [Abstract][Full Text] [Related]
5. The mechanisms of the direct action of etomidate on vascular reactivity in rat mesenteric resistance arteries. Shirozu K; Akata T; Yoshino J; Setoguchi H; Morikawa K; Hoka S Anesth Analg; 2009 Feb; 108(2):496-507. PubMed ID: 19151278 [TBL] [Abstract][Full Text] [Related]
6. Anthracyclines enhance tension development in cardiac muscle by direct interaction with the contractile system. Bottone AE; de Beer EL; Voest EE J Mol Cell Cardiol; 1997 Mar; 29(3):1001-8. PubMed ID: 9152861 [TBL] [Abstract][Full Text] [Related]
7. Thin-filament regulation of force redevelopment kinetics in rabbit skeletal muscle fibres. Moreno-Gonzalez A; Gillis TE; Rivera AJ; Chase PB; Martyn DA; Regnier M J Physiol; 2007 Mar; 579(Pt 2):313-26. PubMed ID: 17204497 [TBL] [Abstract][Full Text] [Related]
8. A simple model with myofilament compliance predicts activation-dependent crossbridge kinetics in skinned skeletal fibers. Martyn DA; Chase PB; Regnier M; Gordon AM Biophys J; 2002 Dec; 83(6):3425-34. PubMed ID: 12496109 [TBL] [Abstract][Full Text] [Related]
9. Rapamycin-mediated inhibition of mammalian target of rapamycin in skeletal muscle cells reduces glucose utilization and increases fatty acid oxidation. Sipula IJ; Brown NF; Perdomo G Metabolism; 2006 Dec; 55(12):1637-44. PubMed ID: 17142137 [TBL] [Abstract][Full Text] [Related]
10. Knock-in mouse model of dilated cardiomyopathy caused by troponin mutation. Du CK; Morimoto S; Nishii K; Minakami R; Ohta M; Tadano N; Lu QW; Wang YY; Zhan DY; Mochizuki M; Kita S; Miwa Y; Takahashi-Yanaga F; Iwamoto T; Ohtsuki I; Sasaguri T Circ Res; 2007 Jul; 101(2):185-94. PubMed ID: 17556660 [TBL] [Abstract][Full Text] [Related]
12. Rapamycin blunts nutrient stimulation of eIF4G, but not PKCepsilon phosphorylation, in skeletal muscle. Vary TC; Anthony JC; Jefferson LS; Kimball SR; Lynch CJ Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E188-96. PubMed ID: 17389711 [TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of rapamycin and octreotide as single agents or in combination in neuroendocrine tumors. Moreno A; Akcakanat A; Munsell MF; Soni A; Yao JC; Meric-Bernstam F Endocr Relat Cancer; 2008 Mar; 15(1):257-66. PubMed ID: 18310292 [TBL] [Abstract][Full Text] [Related]
14. Potent stimulation of myofilament force and ATPase activity of skeletal muscle by eudistomin M, a novel Ca(++)-sensitizing agent from a Caribbean tunicate. Ohizumi Y; Matsunaga K; Nakatani K; Kobayashi J J Pharmacol Exp Ther; 1998 May; 285(2):695-9. PubMed ID: 9580615 [TBL] [Abstract][Full Text] [Related]
15. Noradrenaline-induced increases in calcium and tension in skeletal muscle conductance and resistance arteries from rats with post-infarction heart failure. Trautner S; Amtorp O; Boesgaard S; Andersen CB; Galbo H; Haunsoe S; Sheykhzade M Eur J Pharmacol; 2006 May; 537(1-3):143-54. PubMed ID: 16626691 [TBL] [Abstract][Full Text] [Related]
16. Antidepressive-like effects of rapamycin in animal models: Implications for mTOR inhibition as a new target for treatment of affective disorders. Cleary C; Linde JA; Hiscock KM; Hadas I; Belmaker RH; Agam G; Flaisher-Grinberg S; Einat H Brain Res Bull; 2008 Jul; 76(5):469-73. PubMed ID: 18534253 [TBL] [Abstract][Full Text] [Related]
17. Thymol: a classical small-molecule compound that has a dual effect (potentiating and inhibitory) on myosin. Tamura T; Iwamoto H Biochem Biophys Res Commun; 2004 Jun; 318(3):786-91. PubMed ID: 15144906 [TBL] [Abstract][Full Text] [Related]
18. Acto-myosin crossbridge kinetics in humans with coronary artery disease: influence of sex and diabetes mellitus. Fukagawa NK; Palmer BM; Barnes WD; Leavitt BJ; Ittleman FP; Lewinter MM; Maughan DW J Mol Cell Cardiol; 2005 Nov; 39(5):743-53. PubMed ID: 16171812 [TBL] [Abstract][Full Text] [Related]
19. Ca2+ activation of diffusible and bound pools of mu-calpain in rat skeletal muscle. Murphy RM; Verburg E; Lamb GD J Physiol; 2006 Oct; 576(Pt 2):595-612. PubMed ID: 16857710 [TBL] [Abstract][Full Text] [Related]